Biotech IV Monitor

ARNA — Arena Pharmaceuticals Inc.

Acquired by Pfizer · March 2022
Arena Pharmaceuticals Inc. was acquired by Pfizer in March 2022. ARNA no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Pfizer, and their dates may not have been updated since.

Clinical trial readout dates for Arena Pharmaceuticals Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced.

In progress, no date published

Phase 2a SENS-401
Cisplatin-Induced Ototoxicity
date not published
Ongoing

Discussion

No messages yet. If you follow ARNA, you can start the conversation.
Contact — questions or corrections about ARNA: dukeupt@gmail.com